Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich plasma and hyaluronic acid in shoulder tendon injuries
RBR-105wynccPhase 4Not yet recruiting
- Sponsor
- Prevent Senior
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of platelet-rich plasma, hyaluronic acid and triamcinolone in Rotator cuff deficiency (RCD), Shoulder tendon injury, shoulder tendinopathy and 1 more (3 arms), sponsored by Prevent Senior. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
platelet-rich plasmahyaluronic acidtriamcinolone
03
Conditions
Rotator cuff deficiency (RCD)Shoulder tendon injuryshoulder tendinopathyrotator cuff tear
Beyond the preview
Go deeper on RBR-105wyncc.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-105wyncc.